161 related articles for article (PubMed ID: 31702585)
1. Conformational heterogeneity in apo and drug-bound structures of Toxoplasma gondii prolyl-tRNA synthetase.
Mishra S; Malhotra N; Kumari S; Sato M; Kikuchi H; Yogavel M; Sharma A
Acta Crystallogr F Struct Biol Commun; 2019 Nov; 75(Pt 11):714-724. PubMed ID: 31702585
[TBL] [Abstract][Full Text] [Related]
2. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
[TBL] [Abstract][Full Text] [Related]
3. Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.
Yogavel M; Bougdour A; Mishra S; Malhotra N; Chhibber-Goel J; Bellini V; Harlos K; Laleu B; Hakimi MA; Sharma A
PLoS Pathog; 2023 Feb; 19(2):e1011124. PubMed ID: 36854028
[TBL] [Abstract][Full Text] [Related]
4. Conformational changes in human prolyl-tRNA synthetase upon binding of the substrates proline and ATP and the inhibitor halofuginone.
Son J; Lee EH; Park M; Kim JH; Kim J; Kim S; Jeon YH; Hwang KY
Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2136-45. PubMed ID: 24100331
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase.
Jain V; Kikuchi H; Oshima Y; Sharma A; Yogavel M
J Struct Funct Genomics; 2014 Dec; 15(4):181-90. PubMed ID: 25047712
[TBL] [Abstract][Full Text] [Related]
6. A succession of substrate induced conformational changes ensures the amino acid specificity of Thermus thermophilus prolyl-tRNA synthetase: comparison with histidyl-tRNA synthetase.
Yaremchuk A; Tukalo M; Grøtli M; Cusack S
J Mol Biol; 2001 Jun; 309(4):989-1002. PubMed ID: 11399074
[TBL] [Abstract][Full Text] [Related]
7. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
Muench SP; Prigge ST; McLeod R; Rafferty JB; Kirisits MJ; Roberts CW; Mui EJ; Rice DW
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):328-38. PubMed ID: 17327670
[TBL] [Abstract][Full Text] [Related]
8. Recombinant expression, purification, and crystallization of the glutaminyl-tRNA synthetase from Toxoplasma gondii.
van Rooyen JM; Hakimi MA; Belrhali H
Protein Expr Purif; 2015 Jun; 110():115-21. PubMed ID: 25736594
[TBL] [Abstract][Full Text] [Related]
9. A novel crystal form of pyrrolysyl-tRNA synthetase reveals the pre- and post-aminoacyl-tRNA synthesis conformational states of the adenylate and aminoacyl moieties and an asparagine residue in the catalytic site.
Yanagisawa T; Sumida T; Ishii R; Yokoyama S
Acta Crystallogr D Biol Crystallogr; 2013 Jan; 69(Pt 1):5-15. PubMed ID: 23275158
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance.
Tye MA; Payne NC; Johansson C; Singh K; Santos SA; Fagbami L; Pant A; Sylvester K; Luth MR; Marques S; Whitman M; Mota MM; Winzeler EA; Lukens AK; Derbyshire ER; Oppermann U; Wirth DF; Mazitschek R
Nat Commun; 2022 Aug; 13(1):4976. PubMed ID: 36008486
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.
Hewitt SN; Dranow DM; Horst BG; Abendroth JA; Forte B; Hallyburton I; Jansen C; Baragaña B; Choi R; Rivas KL; Hulverson MA; Dumais M; Edwards TE; Lorimer DD; Fairlamb AH; Gray DW; Read KD; Lehane AM; Kirk K; Myler PJ; Wernimont A; Walpole C; Stacy R; Barrett LK; Gilbert IH; Van Voorhis WC
ACS Infect Dis; 2017 Jan; 3(1):34-44. PubMed ID: 27798837
[TBL] [Abstract][Full Text] [Related]
12. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
[TBL] [Abstract][Full Text] [Related]
13. Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development.
Manickam Y; Malhotra N; Mishra S; Babbar P; Dusane A; Laleu B; Bellini V; Hakimi MA; Bougdour A; Sharma A
PLoS Pathog; 2022 Mar; 18(3):e1010363. PubMed ID: 35333915
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of Glutaminyl-tRNA synthetase (TtGlnRS) from Thermus thermophilus HB8 and its complexes.
Nachiappan M; Jain V; Sharma A; Yogavel M; Jeyakanthan J
Int J Biol Macromol; 2018 Dec; 120(Pt B):1379-1386. PubMed ID: 30248426
[TBL] [Abstract][Full Text] [Related]
15. tRNA(Pro) anticodon recognition by Thermus thermophilus prolyl-tRNA synthetase.
Cusack S; Yaremchuk A; Krikliviy I; Tukalo M
Structure; 1998 Jan; 6(1):101-8. PubMed ID: 9493271
[TBL] [Abstract][Full Text] [Related]
16. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase.
Zhou H; Sun L; Yang XL; Schimmel P
Nature; 2013 Feb; 494(7435):121-4. PubMed ID: 23263184
[TBL] [Abstract][Full Text] [Related]
17. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic studies on multiple conformational states of active-site loops in pyrrolysyl-tRNA synthetase.
Yanagisawa T; Ishii R; Fukunaga R; Kobayashi T; Sakamoto K; Yokoyama S
J Mol Biol; 2008 May; 378(3):634-52. PubMed ID: 18387634
[TBL] [Abstract][Full Text] [Related]
19. Interplay of substrate polymorphism and conformational plasticity of Plasmodium tyrosyl-tRNA synthetase.
Datt M
Comput Biol Chem; 2021 Dec; 95():107582. PubMed ID: 34571426
[TBL] [Abstract][Full Text] [Related]
20. The structural basis of cysteine aminoacylation of tRNAPro by prolyl-tRNA synthetases.
Kamtekar S; Kennedy WD; Wang J; Stathopoulos C; Söll D; Steitz TA
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1673-8. PubMed ID: 12578991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
